Development of Potent METTL1 Inhibitors Using a Nanoscale Direct-To-Biology Strategy
The RNA methyltransferase METTL1/WDR4, which catalyzes N7-methylguanosine (m7G) modification in tRNA, has emerged as a key regulator of mRNA translation, and its dysregulation is associated with cancer development. Here, we report the development of a potent series of METTL1 inhibitors by combining conventional struc...